Kanani, P M; Guse, P A; Smith, W M et al. (1998) Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166. J Cardiovasc Pharmacol 32:42-8
|
Ellinwood Jr, E H; Lee, T H (1997) Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment. NIDA Res Monogr 175:192-207
|
Silvia, C P; Jaber, M; King, G R et al. (1997) Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience 76:737-47
|
King, G R; Ellinwood Jr, E H; Silvia, C et al. (1994) Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function. J Pharmacol Exp Ther 269:743-9
|
King, G R; Joyner, C M; Ellinwood Jr, E H (1994) 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine. Pharmacol Biochem Behav 47:399-407
|
King, G R; Joyner, C; Ellinwood Jr, E H (1994) Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal. Pharmacol Biochem Behav 49:883-9
|
King, G R; Joyner, C; Ellinwood Jr, E H (1994) Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal. Pharmacol Biochem Behav 47:451-7
|
Silvia, C P; King, G R; Lee, T H et al. (1994) Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine. Mol Pharmacol 46:51-7
|
King, G R; Joyner, C; Lee, T H et al. (1993) Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion. Pharmacol Biochem Behav 44:253-62
|
King, G R; Kuhn, C; Ellinwood Jr, E H (1993) Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology (Berl) 111:179-84
|
Showing the most recent 10 out of 20 publications